|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Division of Cardiology, Durham VA and Duke University Medical Center, Durham, NC, USA
2 Department of Biomedical Sciences, University of Missouri, Columbia, MO, USA
3 Procter and Gamble Pharmeceuticals, Mason, OH, USA
* To whom correspondence should be addressed. E-mail: annex001{at}mc.duke.edu.
Peripheral arterial occlusive disease (PAOD) is now recognized as a combination of clinical syndromes that are associated with significant morbidity and mortality. The primary pathophysiology of PAOD is impaired perfusion to the lower extremity. Effective pharmacotherapy designed to increase perfusion in PAOD is lacking and revascularization options are suboptimal. New and more efficacious therapies that improve blood flow are definitely needed and designing, describing, and validating these new therapies in preclinical PAOD models will be essential. This manuscript describes the various pre-clinical PAOD models currently in use, correlates the models to human PAOD, and reviews the available endpoints that can be used to detect a response to therapy.
This article has been cited by other articles:
![]() |
J. Xing, J. Lu, and J. Li Contribution of nerve growth factor to augmented TRPV1 responses of muscle sensory neurons by femoral artery occlusion Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1380 - H1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Taylor, H. T. Yang, M. H. Laughlin, and R. L. Terjung {alpha}-Adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training J. Physiol., December 15, 2008; 586(24): 5983 - 5998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Krady, J. Zeng, J. Yu, S. MacLauchlan, E. A. Skokos, W. Tian, P. Bornstein, W. C. Sessa, and T. R. Kyriakides Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis Am. J. Pathol., September 1, 2008; 173(3): 879 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xing, Z. Gao, J. Lu, L. I. Sinoway, and J. Li Femoral artery occlusion augments TRPV1-mediated sympathetic responsiveness Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1262 - H1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Ji, F. Mac Gabhann, and A. S. Popel Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Penuelas, X. L. Aranguren, G. Abizanda, J. M. Marti-Climent, M. Uriz, M. Ecay, M. Collantes, G. Quincoces, J. A. Richter, and F. Prosper 13N-Ammonia PET as a Measurement of Hindlimb Perfusion in a Mouse Model of Peripheral Artery Occlusive Disease J. Nucl. Med., July 1, 2007; 48(7): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mac Gabhann, J. W. Ji, and A. S. Popel VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle J Appl Physiol, February 1, 2007; 102(2): 722 - 734. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |